Journal
BLOOD
Volume 107, Issue 6, Pages 2303-2310Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2005-07-3005
Keywords
-
Categories
Ask authors/readers for more resources
A major determinant in platelet production is the megakaryocyte (MK) size that is regulated both by ploidlization and the increase in cytoplasmic volume at the end of maturation. Here we investigated the involvement of the mammalian target of rapamycin (mTOR) pathway in the regulation of megakaryopoiesis. We show that phosphorylation of mTOR, p70S6K1, and 4E-BP1 was diminished in thrombopoietin-cultured human MKS after rapamycin treatment. Rapamycin induced an inhibition in the G(1)/S transition and a decrease in the mean MK ploidy via a diminution of p21 and cyclin D3 occurring at a transcriptional level. Both cycling (2N/4N) and polyploid (8N/16N) MKs were reduced in size, with a size reduction slightly more pronounced in mature polyploid MKs than in immature ones. Rapamycin also indued a delay in the expression of MK markers and prevented the generation of proplatelet MKs. Additional experiments performed in vitro with MKs from mutant mice showed that the decrease in mean ploidy level and the delay in MK differentiation in the presence of rapamycin were less pronounced in Cdknia (p21)(-/-) MKs than in Cdknia (p21)(+/+) MKs. These findings indicate that the mTOR pathway plays an important role during megakaryopoiesis by regulating ploidy, cell size, and maturation, in part by regulating p21 and cyclin D3.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available